Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 6.17 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 2.43 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 1.99 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 2.18 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 1.36 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 3.34 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 2.84 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 7.9 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 0.0 | BCD100624C001 | 1.49 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 0.5 | BCD100624C003 | 1.14 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 1.0 | BCD100624C007 | 4.09 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 2.0 | BCD100624C011 | 5.55 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 4.0 | BCD100624C015 | 1.27 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 8.0 | BCD100624C019 | 0.34 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 12.0 | BCD100624C023 | 1.06 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 24.0 | BCD100624C027 | - | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 1.6 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 3.67 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 5.22 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 0.89 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 6.35 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 6.87 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 14.9 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 0.5 | BCD100624C004 | 0.3 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 1.0 | BCD100624C008 | 4.94 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 2.0 | BCD100624C012 | 2.05 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 4.0 | BCD100624C016 | 2.38 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 8.0 | BCD100624C020 | 2.8 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 12.0 | BCD100624C024 | 1.77 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 24.0 | BCD100624C028 | 3.75 | pmol/sample |